Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 2/20 | 0.43 |
| ▸ | KMO | O15229 | 1/20 | 0.36 |
| ▸ | TYMS | P04818 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.33 |
| ▸ | CCKAR | P32238 | 1/20 | 0.33 |
| ▸ | PTGER1 | P34995 | 4/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6334304 | 0.79 | CCKBR (0.60) | CCKBRKMOCCKARPTGER1 | |
| SCHEMBL6334312 | 0.70 | CCKBR (0.49) | CCKBR | |
| SCHEMBL7043738 | 0.69 | CCKBR (0.37) | CCKBR | |
| SCHEMBL6158876 | 0.65 | CCKBR (0.64) | CCKBRCCKAR | |
| SCHEMBL6332353 | 0.64 | CCKBR (0.59) | CCKBRKMOCCKAR | |
| SCHEMBL27959298 | 0.64 | KMO (0.51) | KMOMAOAMAOBKDM4CHSD11B1 | |
| SCHEMBL182018 | 0.63 | KDM4E (0.48) | KMOMAOAMAOB | |
| SCHEMBL27959287 | 0.62 | KMO (0.49) | KMOMAOAMAOBKDM4C | |
| SCHEMBL6159682 | 0.61 | CCKBR (1.00) | CCKBR | |
| SCHEMBL6160905 | 0.61 | CCKBR (1.00) | CCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030199565-A1 | Gastrin and cholecystokinin receptor ligands(II) | JAMES BLACK FOUNDATION LIMITED (GB) | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199565-A1 | Gastrin and cholecystokinin receptor ligands(II) | GRPR, CCKBR, GIPR | CCKBR 2/4885KMO 3972/4885TYMS 3518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.